Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C-(3-((fenyl)metyl)fenyl)-D-glucitol-derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Gougoutas, Jack Z Wang, Chenchi Lai, Chiajen Nirschi, Alexandra A Dimarco, John D Bien, Jeffrey T Singh, Janak Lobinger, Hildegard Riebel, Peter Deshpande, Prashant P Grosso, John Anthony Ramakrishnan, Srividya |
| description | The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor for treating diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO347770BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO347770BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO347770BB13</originalsourceid><addsrcrecordid>eNqNjk1uwkAMhbPpArW9wyyDhKWGUGXPb6WisoA9chgnGWVmHI0HpBypt-wgegA2tj_r6b03yX6_wygRrTVeelLC9oaRguJW9ewGS70kwpvKi-MUitknoO9GHRj2sIK8hDxvyI926iim-bhhDa29XkxkC5qCeVg60gqd8SxjSCjs1HG3P83B-M7USXz_NhxUTR16nRq192BtsKZI8pa9NGiF3v_3a6a2m9PqC2jgM8mAF_IUzz-HclFV1cdyWZRPSP4A8C1Vuw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C-(3-((fenyl)metyl)fenyl)-D-glucitol-derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes</title><source>esp@cenet</source><creator>Gougoutas, Jack Z ; Wang, Chenchi ; Lai, Chiajen ; Nirschi, Alexandra A ; Dimarco, John D ; Bien, Jeffrey T ; Singh, Janak ; Lobinger, Hildegard ; Riebel, Peter ; Deshpande, Prashant P ; Grosso, John Anthony ; Ramakrishnan, Srividya</creator><creatorcontrib>Gougoutas, Jack Z ; Wang, Chenchi ; Lai, Chiajen ; Nirschi, Alexandra A ; Dimarco, John D ; Bien, Jeffrey T ; Singh, Janak ; Lobinger, Hildegard ; Riebel, Peter ; Deshpande, Prashant P ; Grosso, John Anthony ; Ramakrishnan, Srividya</creatorcontrib><description>The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor for treating diabetes.</description><language>nor</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240318&DB=EPODOC&CC=NO&NR=347770B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240318&DB=EPODOC&CC=NO&NR=347770B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gougoutas, Jack Z</creatorcontrib><creatorcontrib>Wang, Chenchi</creatorcontrib><creatorcontrib>Lai, Chiajen</creatorcontrib><creatorcontrib>Nirschi, Alexandra A</creatorcontrib><creatorcontrib>Dimarco, John D</creatorcontrib><creatorcontrib>Bien, Jeffrey T</creatorcontrib><creatorcontrib>Singh, Janak</creatorcontrib><creatorcontrib>Lobinger, Hildegard</creatorcontrib><creatorcontrib>Riebel, Peter</creatorcontrib><creatorcontrib>Deshpande, Prashant P</creatorcontrib><creatorcontrib>Grosso, John Anthony</creatorcontrib><creatorcontrib>Ramakrishnan, Srividya</creatorcontrib><title>Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C-(3-((fenyl)metyl)fenyl)-D-glucitol-derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes</title><description>The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor for treating diabetes.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjk1uwkAMhbPpArW9wyyDhKWGUGXPb6WisoA9chgnGWVmHI0HpBypt-wgegA2tj_r6b03yX6_wygRrTVeelLC9oaRguJW9ewGS70kwpvKi-MUitknoO9GHRj2sIK8hDxvyI926iim-bhhDa29XkxkC5qCeVg60gqd8SxjSCjs1HG3P83B-M7USXz_NhxUTR16nRq192BtsKZI8pa9NGiF3v_3a6a2m9PqC2jgM8mAF_IUzz-HclFV1cdyWZRPSP4A8C1Vuw</recordid><startdate>20240318</startdate><enddate>20240318</enddate><creator>Gougoutas, Jack Z</creator><creator>Wang, Chenchi</creator><creator>Lai, Chiajen</creator><creator>Nirschi, Alexandra A</creator><creator>Dimarco, John D</creator><creator>Bien, Jeffrey T</creator><creator>Singh, Janak</creator><creator>Lobinger, Hildegard</creator><creator>Riebel, Peter</creator><creator>Deshpande, Prashant P</creator><creator>Grosso, John Anthony</creator><creator>Ramakrishnan, Srividya</creator><scope>EVB</scope></search><sort><creationdate>20240318</creationdate><title>Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C-(3-((fenyl)metyl)fenyl)-D-glucitol-derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes</title><author>Gougoutas, Jack Z ; Wang, Chenchi ; Lai, Chiajen ; Nirschi, Alexandra A ; Dimarco, John D ; Bien, Jeffrey T ; Singh, Janak ; Lobinger, Hildegard ; Riebel, Peter ; Deshpande, Prashant P ; Grosso, John Anthony ; Ramakrishnan, Srividya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO347770BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>Gougoutas, Jack Z</creatorcontrib><creatorcontrib>Wang, Chenchi</creatorcontrib><creatorcontrib>Lai, Chiajen</creatorcontrib><creatorcontrib>Nirschi, Alexandra A</creatorcontrib><creatorcontrib>Dimarco, John D</creatorcontrib><creatorcontrib>Bien, Jeffrey T</creatorcontrib><creatorcontrib>Singh, Janak</creatorcontrib><creatorcontrib>Lobinger, Hildegard</creatorcontrib><creatorcontrib>Riebel, Peter</creatorcontrib><creatorcontrib>Deshpande, Prashant P</creatorcontrib><creatorcontrib>Grosso, John Anthony</creatorcontrib><creatorcontrib>Ramakrishnan, Srividya</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gougoutas, Jack Z</au><au>Wang, Chenchi</au><au>Lai, Chiajen</au><au>Nirschi, Alexandra A</au><au>Dimarco, John D</au><au>Bien, Jeffrey T</au><au>Singh, Janak</au><au>Lobinger, Hildegard</au><au>Riebel, Peter</au><au>Deshpande, Prashant P</au><au>Grosso, John Anthony</au><au>Ramakrishnan, Srividya</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C-(3-((fenyl)metyl)fenyl)-D-glucitol-derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes</title><date>2024-03-18</date><risdate>2024</risdate><abstract>The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor for treating diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | nor |
| recordid | cdi_epo_espacenet_NO347770BB1 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C-(3-((fenyl)metyl)fenyl)-D-glucitol-derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A42%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gougoutas,%20Jack%20Z&rft.date=2024-03-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO347770BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |